In this presentation, Mikhaylo Szczupak, MD, explains the pathophysiology mediating allergic disease. He also describes the role and contraindications to immunotherapy in patients with allergic rhinitis and provides an overview of other treatment options.
Upon completion of this activity, participants should be able to:
Dr. Szczupak has reported no relevant relationships with entities producing health care goods or services.
No members of the planning committee, speakers, presenters, authors, content reviewers and/or anyone else in a position to control the content of this education activity have relevant financial relationships with any companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
The University of Pittsburgh designates enduring material activity for a maximum of .75 AMA PRA Category 1 Credit[s]™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity.
For your credit transcript, please access our website four weeks post completion at http://ccehs.upmc.com and follow the link to the Credit Transcript page.
Release Date: 5/24/2022 | Last Modified On: 5/24/2022 | Expires: 5/24/2023